The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care.
British Thoracic Society
Patients at risk of severe exacerbations contribute disproportionally to asthma mortality, morbidity and costs. We evaluated the effectiveness and costs of using 'asthma risk registers' for these patients in primary care.
This article has been accepted for publication in Thorax, following peer review. The definitive copyedited, typeset version - Thorax, 2012 Dec;67(12)p.1052-60 - is available online at: http://thorax.bmj.com/content/67/12/1052.long
Thorax, 2012, Vol. 67, Issue 12, pp. 1052 - 1060
Place of publication